Clinical Trial Update: The BENeFiTS Trial in Beta Thalassemia Intermedia [Phase 1, Phase 2]

View source ↗

Summary

The BENeFiTS trial is a Phase 1/2 study in beta-thalassemia intermedia and sickle cell disease that is currently enrolling by invitation, sponsored by Phoenicia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia Intermedia
• Sickle Cell Disease

Snippet

Sponsor: Phoenicia BioScience | Conditions: Beta Thalassemia Intermedia, Sickle Cell Disease | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION